Transgene Confirms the Potential of Its Two Innovative Platforms and Expects Significant Clinical Results in 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Ben Brahim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Regulatory News: Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today publishes its financial
Transgene Appoints Steven Bloom as Chief Business Officer - read this article along with other careers information, tips and advice on BioSpace
Transgene to receive $8 million upfront option exercise payment Conference call today on December 15, 2021, at 6:00 p.m. CET (12:00 p.m. ET) in English (details at the end of the release) Regulatory
Press release content from Business Wire. The AP news staff was not involved in its creation.